Logo image of EFSH

1847 Holdings LLC (EFSH) Stock Fundamental Analysis

NYSEARCA:EFSH - NYSE Arca - US28252B8533 - Common Stock - Currency: USD

0.0707  -0.05 (-40.34%)

Fundamental Rating

1

Overall EFSH gets a fundamental rating of 1 out of 10. We evaluated EFSH against 6 industry peers in the Industrial Conglomerates industry. EFSH may be in some trouble as it scores bad on both profitability and health. EFSH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EFSH had negative earnings in the past year.
EFSH had a negative operating cash flow in the past year.
In the past 5 years EFSH always reported negative net income.
EFSH had a negative operating cash flow in each of the past 5 years.
EFSH Yearly Net Income VS EBIT VS OCF VS FCFEFSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -264.88%, EFSH is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -264.88%
ROE N/A
ROIC N/A
ROA(3y)-46.7%
ROA(5y)-50.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EFSH Yearly ROA, ROE, ROICEFSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

EFSH's Gross Margin of 33.41% is fine compared to the rest of the industry. EFSH outperforms 62.50% of its industry peers.
EFSH's Gross Margin has declined in the last couple of years.
EFSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.63%
GM growth 5Y-12.72%
EFSH Yearly Profit, Operating, Gross MarginsEFSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

0

2. Health

2.1 Basic Checks

EFSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
EFSH has more shares outstanding than it did 1 year ago.
EFSH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for EFSH is higher compared to a year ago.
EFSH Yearly Shares OutstandingEFSH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K
EFSH Yearly Total Debt VS Total AssetsEFSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -8.04, we must say that EFSH is in the distress zone and has some risk of bankruptcy.
EFSH's Altman-Z score of -8.04 is fine compared to the rest of the industry. EFSH outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.04
ROIC/WACCN/A
WACC11.85%
EFSH Yearly LT Debt VS Equity VS FCFEFSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.70 indicates that EFSH may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.70, EFSH is doing worse than 62.50% of the companies in the same industry.
A Quick Ratio of 0.66 indicates that EFSH may have some problems paying its short term obligations.
EFSH has a worse Quick ratio (0.66) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.66
EFSH Yearly Current Assets VS Current LiabilitesEFSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2

3. Growth

3.1 Past

The earnings per share for EFSH have decreased strongly by -56.26% in the last year.
The Revenue for EFSH has decreased by -30.04% in the past year. This is quite bad
EFSH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.42% yearly.
EPS 1Y (TTM)-56.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%614.45%
Revenue 1Y (TTM)-30.04%
Revenue growth 3Y98.77%
Revenue growth 5Y56.42%
Sales Q2Q%-74.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EFSH Yearly Revenue VS EstimatesEFSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

EFSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EFSH Price Earnings VS Forward Price EarningsEFSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EFSH Per share dataEFSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EFSH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

1847 Holdings LLC

NYSEARCA:EFSH (4/3/2025, 8:04:00 PM)

0.0707

-0.05 (-40.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)04-15 2025-04-15
Inst Owners1.16%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner Change0%
Market Cap1.88M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.22
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-369.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS1.6
BVpS-0.92
TBVpS-1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -264.88%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.41%
FCFM N/A
ROA(3y)-46.7%
ROA(5y)-50.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.63%
GM growth 5Y-12.72%
F-Score2
Asset Turnover2.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.66
Altman-Z -8.04
F-Score2
WACC11.85%
ROIC/WACCN/A
Cap/Depr(3y)14.29%
Cap/Depr(5y)19.17%
Cap/Sales(3y)0.48%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%614.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.04%
Revenue growth 3Y98.77%
Revenue growth 5Y56.42%
Sales Q2Q%-74.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-134.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-153.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-163.27%
OCF growth 3YN/A
OCF growth 5YN/A